RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 19 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $10,000 | 0.0% | 17,974 | -9.9% | 0.00% | – |
Q3 2017 | $10,000 | -16.7% | 19,944 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | -84.0% | 19,944 | -78.5% | 0.00% | – |
Q1 2017 | $75,000 | +13.6% | 92,755 | 0.0% | 0.00% | – |
Q4 2016 | $66,000 | -59.3% | 92,755 | +4.8% | 0.00% | – |
Q3 2016 | $162,000 | -31.1% | 88,509 | -9.6% | 0.00% | – |
Q2 2016 | $235,000 | – | 97,893 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 397,371 | $284,000 | 0.02% |
Hudson Bay Capital Management LP | 428,812 | $306,000 | 0.00% |
FNY Partners Fund LP | 179 | $0 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 38 | $0 | 0.00% |
Virtu KCG Holdings LLC | 27,689 | $20,000 | 0.00% |
IFP Advisors, Inc | 1 | $0 | 0.00% |
Advisor Group, Inc. | 163 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,096 | $1,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 26,638 | $19,000 | 0.00% |
DEUTSCHE BANK AG\ | 1,396 | $0 | 0.00% |